Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

ConditionCKD
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Comparing between the efficacy of alternate day oral iron dose, once daily and thrice daily dose in improving anemia in CKD patients

Eligibility criteria

Qualifiers

All adult patients above 18 years old with CKD stages 2,3 and 4

Disqualifiers

CKD stage 5 (eGFR below 15 ).

Patients with hemolytic anemias.

Chronic liver diseases .

Autoimmune diseases.

Trial design

Treatments tested in this trial

  • Ferrous sulfate

Treatment groups

150 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators